MPM BioImpact

MPM BioImpact is a world-leading biotechnology investment firm with nearly three decades of experience creating and investing in companies that seek to translate scientific innovations into cures for major diseases. With its world-class team and deep experience in scientific research, clinical development, and company-building, MPM BioImpact strives to power novel medical breakthroughs that transform patients lives. MPM BioImpact invests across the biotech landscape from early stage start-ups to public companies

Cancer therapy,disease treatment,funding companies to make a difference,pharmaceuticals,investment,biotech,venture creation,and therapeutics

Mpm bioimpact operates in the Venture capital and private equity principals industry.

Mpm bioimpact's revenue is 11m - 100m

Mpm bioimpact has 51 - 200 employees.